Group 1 - The core viewpoint of the article highlights that Shanghai Meino Biological Technology Co., Ltd. (Meino Bio) has experienced significant growth in revenue and net profit in the first half of 2025, driven by innovative product development and strategic market expansion [1] - The company’s revenue from its feed additive segment, particularly gut health products, has increased by over 60% year-on-year, marking it as a key growth driver [1] - Meino Bio's strategy focuses on both domestic market deepening and international market breakthroughs, achieving over 20% revenue growth in overseas markets by expanding into more than 10 new markets including Australia, New Zealand, and Indonesia [1][2] Group 2 - The company’s wholly-owned subsidiary, Meino Biological Technology (Leling) Co., Ltd., is progressing well with its 100,000-ton corn protein deep processing project, expected to enter trial production within the year [2] - The feed additive industry is experiencing a clear growth trend, driven by the scale of livestock farming and the demand for new environmentally friendly additives, alongside regulatory pressures promoting green additive development [2] - Meino Bio aims to become a "global livestock resource integration platform," exporting high-quality domestic products while introducing advanced products from regions like Europe to enhance domestic feed and breeding enterprises [3]
美农生物接受多家机构调研 国际化布局与新项目投产构筑新增长极